GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (AMEX:XTNT) » Definitions » E10

Xtant Medical Holdings (Xtant Medical Holdings) E10 : $-10.37 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Xtant Medical Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Xtant Medical Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-10.37 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 10.90% per year. During the past 5 years, the average E10 Growth Rate was 17.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Xtant Medical Holdings was 21.20% per year. The lowest was 10.90% per year. And the median was 14.00% per year.

As of today (2024-05-26), Xtant Medical Holdings's current stock price is $0.7511. Xtant Medical Holdings's E10 for the quarter that ended in Mar. 2024 was $-10.37. Xtant Medical Holdings's Shiller PE Ratio of today is .


Xtant Medical Holdings E10 Historical Data

The historical data trend for Xtant Medical Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings E10 Chart

Xtant Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.02 -15.97 -16.18 -14.64 -11.30

Xtant Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.31 -13.66 -12.52 -11.30 -10.37

Competitive Comparison of Xtant Medical Holdings's E10

For the Medical Devices subindustry, Xtant Medical Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Shiller PE Ratio falls into.



Xtant Medical Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xtant Medical Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.03/131.7762*131.7762
=-0.030

Current CPI (Mar. 2024) = 131.7762.

Xtant Medical Holdings Quarterly Data

per share eps CPI Adj_EPS
201406 -3.820 100.560 -5.006
201409 -2.074 100.428 -2.721
201412 -5.348 99.070 -7.114
201503 -6.767 99.621 -8.951
201506 -4.475 100.684 -5.857
201509 -6.985 100.392 -9.169
201512 10.587 99.792 13.980
201603 -5.596 100.470 -7.340
201606 -4.405 101.688 -5.708
201609 -4.762 101.861 -6.161
201612 -3.691 101.863 -4.775
201703 -3.840 102.862 -4.919
201706 -6.383 103.349 -8.139
201709 -5.579 104.136 -7.060
201712 -18.683 104.011 -23.670
201803 -0.695 105.290 -0.870
201806 -0.377 106.317 -0.467
201809 -0.238 106.507 -0.294
201812 -4.279 105.998 -5.320
201903 -0.208 107.251 -0.256
201906 -0.149 108.070 -0.182
201909 -0.139 108.329 -0.169
201912 -0.129 108.420 -0.157
202003 -0.190 108.902 -0.230
202006 -0.190 108.767 -0.230
202009 -0.100 109.815 -0.120
202012 -0.010 109.897 -0.012
202103 0.000 111.754 0.000
202106 -0.010 114.631 -0.011
202109 -0.020 115.734 -0.023
202112 -0.030 117.630 -0.034
202203 -0.030 121.301 -0.033
202206 -0.020 125.017 -0.021
202209 -0.030 125.227 -0.032
202212 -0.020 125.222 -0.021
202303 -0.020 127.348 -0.021
202306 -0.020 128.729 -0.020
202309 0.070 129.860 0.071
202312 -0.030 129.419 -0.031
202403 -0.030 131.776 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.


Xtant Medical Holdings  (AMEX:XTNT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Xtant Medical Holdings E10 Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtant Medical Holdings (Xtant Medical Holdings) Business Description

Traded in Other Exchanges
Address
664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Executives
Kevin D Brandt officer: VP & Chief Commercial Officer 11621 RESEARCH CIRCLE, ALACHUA FL 32615
Lori D Mitchell-keller director 664 CRUISER LANE, BELGRADE MT 59714
Jonn R. Beeson director 664 CRUISER LANE, BELGRADE MT 59714
Scott C Neils officer: Interim CFO 664 CRUISER LANE, BELGRADE MT 59714
Mark A. Schallenberger officer: Chief Operations Officer 664 CRUISER LANE, BELGRADE MT 59714
Sean E Browne officer: President and CEO 664 CRUISER LANE, BELGRADE MT 59714
Stavros G. Vizirgianakis director 1/16-18 TENNYSON ST., WILLIAMSTOWN NORTH, VICTORIA CA 3016
Orbimed Rof Ii Llc director, 10 percent owner 601 LEXINGTON AVE., 54TH FLOOR, NEW YORK NY 10022
Greg Jensen officer: VP, Finance and Interim CFO 664 CRUISER LANE, BELGRADE MT 59714
Ronald G. Berlin officer: VP & Chief Operations Officer 664 CRUISER LANE, BELGRADE MT 59714
Kathie J. Lenzen officer: SVP Fiance & Admin. & CFO 664 CRUISER LANE, BELGRADE MT 59714
Orbimed Advisors Llc 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Matthew Rizzo director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Michael Eggenberg director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Robert Mcnamara director C/O LDR HOLDING CORPORATION, 13785 RESEARCH BOULEVARD, SUITE 200, AUSTIN TX 78750

Xtant Medical Holdings (Xtant Medical Holdings) Headlines

From GuruFocus